Published in Z Kardiol on May 01, 1987
Safety of transesophageal echocardiography. A multicenter survey of 10,419 examinations. Circulation (1991) 3.70
The safety and efficacy of an extravascular, water-soluble sealant for vascular closure: initial clinical results for Mynx. Catheter Cardiovasc Interv (2007) 1.63
Automatic implantable cardioverter/defibrillator (AICD) and antitachycardia pacemaker (Tachylog): combined use in ventricular tachyarrhythmias. Pacing Clin Electrophysiol (1986) 1.42
Emergency polytetrafluoroethylene-covered stent implantation to treat coronary ruptures. Circulation (2000) 1.17
Effects of verapamil on P-R-intervals in relation to verapamil plasma levels following single I.V. and oral administration and during chronic treatment. Klin Wochenschr (1980) 1.16
Balloon-protected carotid artery stenting: relationship of periprocedural neurological complications with the size of particulate debris. Circulation (2001) 1.04
Non-invasive diagnosis of a false left ventricular aneurysm by echocardiography and pulsed Doppler echocardiography. Br Heart J (1980) 1.02
Novel drug-delivery stent: intravascular ultrasound observations from the first human experience with the QP2-eluting polymer stent system. Circulation (2001) 1.01
Evolution of insular Pacific Pittosporum (Pittosporaceae): origin of the Hawaiian radiation. Mol Phylogenet Evol (2002) 0.99
Management of arterial puncture site after catheterization procedures: evaluating a suture-mediated closure device. Am J Cardiol (1999) 0.97
Sodium intake modulates left ventricular hypertrophy in essential hypertension. J Hypertens Suppl (1988) 0.90
Prevention of distal embolization during coronary angioplasty in saphenous vein grafts and native vessels using porous filter protection. Circulation (2001) 0.89
[Position paper on the use of drug eluting stents in coronary heart disease]. Z Kardiol (2004) 0.85
Incidental finding of a papillary fibroelastoma on the aortic valve in 16 slice multi-detector row computed tomography. Heart (2004) 0.85
Pharmacokinetic and pharmacodynamic properties of ramipril in patients with congestive heart failure (NYHA III-IV). J Cardiovasc Pharmacol (1989) 0.84
Chronic sulfur dioxide exposure in a smelter. I. Exposure to SO2 and dust: 1940-1974. J Occup Med (1978) 0.82
Intravenous quinidine: pharmacokinetic properties and effects on left ventricular performance in humans. Am Heart J (1980) 0.82
Advances in percutaneous treatment for adult valvular heart disease. Intern Med J (2009) 0.81
First experience with the Impella Recover(R) LP 2.5 micro axial pump in patients with cardiogenic shock or undergoing high-risk revascularisation. EuroIntervention (2006) 0.81
Drug-eluting stents: clinical experiences and perspectives. Minerva Cardioangiol (2002) 0.81
Images in cardiology. Optical coherence tomography imaging of thrombus protrusion through stent struts after stenting in acute coronary syndrome. Heart (2006) 0.81
Long-term evaluation of paclitaxel-coated stents for treatment of native coronary lesions. First results of both the clinical and angiographic 18 month follow-up of TAXUS I. Z Kardiol (2003) 0.80
Effects of octreotide treatment on restenosis after coronary angioplasty: results of the VERAS study. VErringerung der Restenoserate nach Angioplastie durch ein Somatostatin-analogon. Circulation (1997) 0.80
[Brugada syndrome or ARVD (arrhythmogenic right ventricular dysplasia) or both? Significance and value of right precordial ECG changes]. Z Kardiol (2002) 0.79
[Determination of the severity of mitral stenosis by hemodynamic and echocardiographic parameters]. Z Kardiol (1978) 0.79
[Steroid glucuronyltransferases. II. Solubilization, purification aand kinetic properties of oestradiol-17 3-glucuronyltransferase from the microsomal fraction of pig intestine]. Hoppe Seylers Z Physiol Chem (1971) 0.79
[Combination of sotalol with the class I B substances mexiletine or tocainide in complex ventricular extrasystole]. Z Kardiol (1987) 0.79
Current concepts in the treatment of cardiac arrhythmias. J Cardiovasc Pharmacol (1986) 0.78
Percutaneous transluminal coronary angioplasty of left main stenosis--results of the German PTCA registry. Z Kardiol (2000) 0.78
First-In-Man application of a miniature self-contained intracoronary magnetic resonance probe. A multi-centre safety and feasibility trial. EuroIntervention (2006) 0.77
Laser angioplasty of restenosed coronary stents: results of a multicenter surveillance trial. The Laser Angioplasty of Restenosed Stents (LARS) Investigators. J Am Coll Cardiol (1999) 0.77
Determinants of mortality after cardiac surgery: results of the registry of the Arbeitsgemeinschaft Leitender Kardiologischer Krankenhausärzte (ALKK) on 10 525 patients. Eur Heart J (2000) 0.77
Combination of antitachycardia pacemaker and automatic implantable cardioverter/defibrillator for ventricular tachycardia. Pacing Clin Electrophysiol (1986) 0.77
[Electrophysiologic effects of diprafenone in supraventricular and ventricular tachycardia]. Z Kardiol (1986) 0.77
Occupational safety and health implications of increased coal utilization. Environ Health Perspect (1979) 0.77
Drug eluting stents: initial experiences. Z Kardiol (2002) 0.76
Erroneous discharge from an implanted automatic defibrillator during supraventricular tachyarrhythmia induced ventricular fibrillation. Am J Cardiol (1986) 0.76
Innovations and novel technologies in TAVI. Second generation transcatheter heart valves. Minerva Cardioangiol (2013) 0.75
[Rate-responsive cardiac pacemaker. State of development and clinical value]. Dtsch Med Wochenschr (1987) 0.75
[2-dimensional sector echocardiography]. Dtsch Med Wochenschr (1979) 0.75
[Background and indications for distal protection devices in percutaneous coronary interventions]. Dtsch Med Wochenschr (2006) 0.75
Effects of prostacyclin during cardiopulmonary bypass in men on plasma levels of beta-thromboglobulin, platelet factor 4, thromboxane B2, 6-keto-prostaglandin F1 alpha and heparin. Thromb Res (1983) 0.75
Impact of coronary artery disease on in-hospital mortality in patients with aortic valve disease. Results from the German ALKK registry. Herz (2013) 0.75
[Echocardiographic contrast studies for the delineation of the heart cavities using peripheral venous sodium chloride injections. A contribution to shunt diagnosis]. Verh Dtsch Ges Inn Med (1978) 0.75
[Clinical and haemodynamic results with intra-aortic counterpulsation (author's transl)]. Dtsch Med Wochenschr (1975) 0.75
Comparative endoluminal visualization of TAXUS crush-stenting at 9 months follow-up by intravascular ultrasound and optical coherence tomography. Z Kardiol (2005) 0.75
[Fast computer tomography for investigation of the heart--"computer cardiotomography". Methods and early results (author's transl)]. Rofo (1978) 0.75
[Differential indications for anti-arrhythmia therapy]. Internist (Berl) (1987) 0.75
[Therapy of supraventricular reentry tachycardia by implantation of a demand-regulated overdrive pacemaker]. Verh Dtsch Ges Kreislaufforsch (1977) 0.75
[Improving color Doppler echocardiography of the right heart chambers following intravenous injection of SHU 454]. Z Kardiol (1988) 0.75
[Percutaneous suture closure of the femoral artery access after diagnostic heart catheter examination or coronary intervention]. Dtsch Med Wochenschr (1996) 0.75
[Supraventricular tachycardia: the results of bundle of His ablation]. Dtsch Med Wochenschr (1985) 0.75
[Intra-aortic adverse pulsation]. Dtsch Med Wochenschr (1978) 0.75
[Arrangement in nursing home threatens nurses]. Sygeplejersken (1990) 0.75
[Antitachycardia pacing therapy in supraventricular tachycardia using the microcomputer-guided Tachylog 651 pacemaker]. Z Kardiol (1986) 0.75
Final report of the European multi-center registry using the Duett vascular sealing device. Herz (1999) 0.75
A correction in the comparison of 210 Pb skeletal levels with radon daughter exposures. Health Phys (1972) 0.75
[Assessment of the severity of mitral valve insufficiency using color Doppler echocardiography]. Z Kardiol (1989) 0.75
[A rare pacemaker complication of a perforation by a ventricular screw electrode causing hemothorax]. Z Kardiol (1986) 0.75
[Steroid glucuronyltransferases. I. Morphological and biochemical investigations on the oestradiol-17 3-glucuronyltransferase in subcellular fractions of the pig intestine]. Hoppe Seylers Z Physiol Chem (1971) 0.75
[Echocardiography]. Rontgenpraxis (1978) 0.75
Coronary interventions in the elderly--the German ALKK Study Group experience. Z Kardiol (2001) 0.75
[Significance of microproteinuria for early detection of hypertension-induced end organ damage]. Klin Wochenschr (1990) 0.75
[30-day mortality after heart surgery: a pilot project of the Working Party of Directors of Hospital Cardiology Departments]. Dtsch Med Wochenschr (1999) 0.75
Prostacyclin in aortocoronary bypass surgery: a double-blind, placebo-controlled study. Thromb Res (1983) 0.75
[Motion analysis of the left ventricle by two dimensional sector echokardiography (author's transl)]. Z Kardiol (1978) 0.75
[Supraventricular tachycardia: therapy with a variable antitachycardia stimulation program]. Z Kardiol (1988) 0.75
[Cardiomyopathy in progressive muscular dystrophy]. Dtsch Med Wochenschr (1990) 0.75
Clinical and angiographic performance of a new-generation modular stent design for treatment of de novo coronary lesions. Catheter Cardiovasc Interv (2001) 0.75
[Intraoperative measurement of velocity and volume of coronary circulation using the Duplex system]. Z Kardiol (1988) 0.75
[Determinants for myocardial hypertrophy in mild essential hypertension. The effect of sodium chloride on left-ventricular hypertrophy]. Z Kardiol (1990) 0.75
[Clinical experiences with the PercuSurge GuardWire--a new system for prevention of peripheral embolisms in catheter interventions on degenerated coronary artery venous bypasses]. Z Kardiol (2000) 0.75
New aspects of excitation-contraction coupling in cardiac muscle: two types of Ca++ entry promotion with and without involvement of cyclic AMP and Mg++ ions. Basic Res Cardiol (1987) 0.75
[Coronary spasms in selective coronary angiography]. Rofo (1979) 0.75
[Intestinal absorption and metabolism of lanatoside C]. Verh Dtsch Ges Inn Med (1978) 0.75
[Physiologic pacemaker stimulation]. Verh Dtsch Ges Inn Med (1985) 0.75
[Intermittent intra-aortic counterpulsation as therapy in threatening and manifest heart failure]. Verh Dtsch Ges Kreislaufforsch (1976) 0.75
[Functional disorders of chamber demand (VVI) and sequential AV (DDD) pacemakers caused by muscle potentials]. Dtsch Med Wochenschr (1985) 0.75
[Demonstration of left-ventricular contraction anomalies with the two-dimensional sector-scanner (author's transl)]. Dtsch Med Wochenschr (1979) 0.75
Relation of hemodynamic reaction during stress to left ventricular hypertrophy in essential hypertension. Am J Hypertens (1990) 0.75
[Significance of propranolol action on the AH-time for the diagnosis of normal and aberrant atrial-His correlations]. Verh Dtsch Ges Inn Med (1978) 0.75
Coronary stents: In vitro aspects of an angiographic and ultrasound quantification with in vivo correlation. Circulation (1998) 0.75
[Paroxysmal tachycardic atrial fibrillation: termination by surgically induced A-V block (author's transl)]. Dtsch Med Wochenschr (1975) 0.75
[Coronary insufficiency: symptoms and diagnostic assessment. Causal/symptomatic therapy]. Verh Dtsch Ges Inn Med (1990) 0.75
[Determination of the examination planes in two-dimensional sector echocardiography (author's transl)]. Z Kardiol (1979) 0.75
[Comparative postoperative studies following implantation of synthetic and xenograft prosthesis in the mitral position. An echocardiographic study]. Verh Dtsch Ges Inn Med (1978) 0.75
[Effects of prostacyclin (PGI2) on tachycardic heart arrhythmias following aortocoronary venous bypass operations]. Herz (1985) 0.75
[Embolism prevention during interventional treatment of aortocoronary bypass stenoses]. Z Kardiol (2001) 0.75
[Automatic implantable cardioverter-defibrillator (AICD) and antitachycardia pacemaker (Tachylog 651) in the treatment of ventricular tachyarrhythmias]. Z Kardiol (1987) 0.75